Trial of Befizal® 200 mg for the Treatment of Leber Hereditary Optic Neuropathy

Clinical trial NCT04561466 · COMPLETED

Trial details

NCT number: NCT04561466
Sponsor: Hôpital Necker-Enfants Malades
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Safety Issues Efficacy, Self

Start date: 2019-03-26
Primary completion: 2022-12-09
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.